Some meaningful rescheduling chatter • The good and bad in LA’s cannabis budget • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.


House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling 

The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.


What Else Is In HHS’ Cannabis Rescheduling Docs?

Many groups’ work, from CANNRA to the National Academies of Sciences, Engineering, and Medicine, informed a federal recommendation to reclassify cannabis.